This content is machine translated Rosacea - multifaceted and multifactorial Topical and systemic active ingredients: proven and new therapeutic approaches Several risk factors and triggers are known to contribute to the different clinical manifestations of rosacea by activating or modulating neurovascular or immunological processes. Thanks to advances in research into...…
View Post 6 min This content is machine translated Newer treatment options for rosacea Therapy depends on the subtype and severity of rosacea In general, triggering factors should be avoided in all subtypes of rosacea. Metronidazole, azelaic acid (Germany), and brimonidine are approved for local therapy, and doxycycline in subantimicrobial doses (40 mg/d) is…
View Post 4 min This content is machine translated Balanitis An unpleasant phenomenon with many possible causes Balanitis is a common problem and represents a significant limitation for the affected patient. Often, the findings are not limited to the glans, but also spread to the prepuce or…
View Post 4 min This content is machine translated Rosacea Addressing known factors with therapy Although globally accepted international consensus guidelines are lacking for the treatment of rosacea, the numerous therapeutic options are very much based on evidence-based criteria, as PD Dr. med. Peter Häusermann…
